Senzime AB (publ) Stock

Senzime AB (publ) Liabilities 2024

Senzime AB (publ) Liabilities

57.65 M SEK

Ticker

SEZI.ST

ISIN

SE0002478776

WKN

A0X93V

In 2024, Senzime AB (publ)'s total liabilities amounted to 57.65 M SEK, a -5.15% difference from the 60.78 M SEK total liabilities in the previous year.

Senzime AB (publ) Aktienanalyse

What does Senzime AB (publ) do?

Senzime AB is a Swedish medical technology company specializing in the development, production, and marketing of products for monitoring the neuromuscular blockade state and preventing postoperative complications in patients. Founded in 2013, Senzime has become a major provider of medical devices on the global market. Its business model revolves around designing and producing intelligent monitoring devices that allow healthcare professionals to control important patient parameters during anesthesia and the postoperative phase. Senzime has developed various products for monitoring the neuromuscular blockade state, early detection of postoperative complications, and specialized use in intensive care medicine. The company is focused on continuous innovation and collaboration with healthcare professionals, universities, and research institutions to improve its technology and applications. Senzime aims to enhance patient safety and make treatment more effective and secure. Senzime AB (publ) ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Senzime AB (publ)'s Liabilities

Senzime AB (publ)'s liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Senzime AB (publ)'s financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Senzime AB (publ)'s liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Senzime AB (publ)'s total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Senzime AB (publ)’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Senzime AB (publ) stock

What is the level of liabilities of Senzime AB (publ) this year?

Senzime AB (publ) has a debt balance of 57.65 M SEK this year.

What were the liabilities of Senzime AB (publ) compared to the previous year?

The liabilities of Senzime AB (publ) have increased by -5.15% dropped compared to the previous year.

What are the consequences of high debt for investors of Senzime AB (publ)?

High liabilities can pose a risk for investors of Senzime AB (publ), as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Senzime AB (publ)?

Low liabilities mean that Senzime AB (publ) has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Senzime AB (publ) affect the company?

An increase in liabilities of Senzime AB (publ) can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Senzime AB (publ) affect the company?

A decrease in the liabilities of Senzime AB (publ) can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Senzime AB (publ)?

Some factors that can influence the liabilities of Senzime AB (publ) include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Senzime AB (publ) so important for investors?

The liabilities of Senzime AB (publ) are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Senzime AB (publ) take to modify the liabilities?

To change its liabilities, Senzime AB (publ) can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Senzime AB (publ) pay?

Over the past 12 months, Senzime AB (publ) paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Senzime AB (publ) is expected to pay a dividend of 0 SEK.

What is the dividend yield of Senzime AB (publ)?

The current dividend yield of Senzime AB (publ) is .

When does Senzime AB (publ) pay dividends?

Senzime AB (publ) pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Senzime AB (publ)?

Senzime AB (publ) paid dividends every year for the past 0 years.

What is the dividend of Senzime AB (publ)?

For the upcoming 12 months, dividends amounting to 0 SEK are expected. This corresponds to a dividend yield of 0 %.

In which sector is Senzime AB (publ) located?

Senzime AB (publ) is assigned to the 'Health' sector.

Wann musste ich die Aktien von Senzime AB (publ) kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Senzime AB (publ) from 12/26/2024 amounting to 0 SEK, you needed to have the stock in your portfolio before the ex-date on 12/26/2024.

When did Senzime AB (publ) pay the last dividend?

The last dividend was paid out on 12/26/2024.

What was the dividend of Senzime AB (publ) in the year 2023?

In the year 2023, Senzime AB (publ) distributed 0 SEK as dividends.

In which currency does Senzime AB (publ) pay out the dividend?

The dividends of Senzime AB (publ) are distributed in SEK.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Senzime AB (publ)

Our stock analysis for Senzime AB (publ) Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Senzime AB (publ) Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.